Professor Collen Masimirembwa has founded and leads the African Institute of Biomedical Science and Technology (AiBST). Currently, he is the President of the African Pharmacogenomics Consortium (APC). His research focuses on pharmacogenetics and clinical pharmacology. He demonstrated the clinical relevance of Africa’s genomic diversity, especially with respect to the safe use of anti-retroviral drugs.
He is a Distinguished Professor of Health Sciences (Witwatersrand University, South Africa), and a Fellow of the Zimbabwe Academy of Sciences and the African Academy of Sciences. He received many awards including the HUGO Africa Award (2018). Prof. Masimirembwa studied at the University of Zimbabwe and the Karolinska Institute, Sweden (PhD). After having worked for AstraZeneca Pharmaceutical Company as a Principal Scientist for about 10 years, he returned to Africa.